Aetherion Technologies (AETR) Q4 2023 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2023 earnings summary
11 Nov, 2026Executive summary
FY2023 revenue reached a record $331.8M, up 9% YoY; net loss widened to $49.7M from $32.7M, while adjusted EBITDA loss narrowed to $21.5M from $27.8M.
Growth in delayed OEM, electronics, fuel storage and heavy-duty engineering services was partly offset by weaker CNG, IAM sales in Africa and hydrogen sales.
2024 priorities include HPDI JV commercialization, operational excellence and cost reductions, and hydrogen and alternative-fuel innovation.
Financial highlights
FY revenue was $331.8M versus $305.7M; Q4 revenue rose to $87.2M from $78.0M YoY.
FY net loss was $49.7M, or $2.90 per share, versus $32.7M, or $1.91; Q4 net loss was $13.9M, or $0.81 per share, versus $16.9M, or $1.00.
Adjusted EBITDA loss improved by $6.3M to $21.5M for FY2023; Q4 loss narrowed to $10.0M from $12.9M.
A $7.1M Q4 inventory write-down affected heavy-duty OEM, light-duty OEM and IAM; OEM growth more than offset lower IAM revenue.
Outlook and guidance
Expanded Euro 6 and Euro 7 LPG program is forecast to generate ~€255M in total revenue through 2028; initial deliveries began in Q1 2024.
HPDI JV operations were expected in Q2 2024, subject to closing conditions, regulatory and government approvals.
Cost-reduction initiatives target operating and G&A expenses; India restructuring aims to improve capital efficiency and throughput.
Demand is expected to increase, with hydrogen-based transport projected to become competitive with traditional fuels by the 2030s.
Latest events from Aetherion Technologies
- Cespira growth improved results, but liquidity remains insufficient for the next 12 months.AETR
Q3 2026 - Equity facility enables up to $25M in share sales, with major dilution and going concern risks disclosed.AETR
Registration filing - Cespira's rapid growth and new funding contrast with overall losses and liquidity concerns.AETR
Q2 2026 - Resale registration for 4.85M shares via warrants, with proceeds for working capital amid liquidity risks.AETR
Registration filing - Approved name change, advanced strategic partnerships, and strengthened finances; no Q&A raised.AETR
AGM 2026 - Directors and auditors were elected, and strategic focus was set on hydrogen and HPDI growth.AETR
AGM 2024 - Directors elected, auditors reappointed, and major divestiture approved for strategic growth.AETR
AGM 2025 - Cash up, debt down, revenue fell 43%, but margin recovery and growth expected in 2026.AETR
Q4 2025 - Gross margin rose to 31% as Cespira/Sospira JV revenue grew 19% and liquidity improved.AETR
Q3 2025